Spots Global Cancer Trial Database for Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer

Official Title: Evaluating a Novel Follow-up Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer Survivors in Wisconsin

Study ID: NCT05609435

Conditions

Breast Cancer

Interventions

REASSURE

Study Description

Brief Summary: This study tests a novel intervention designed to optimize needed survivorship care for low-risk breast cancer survivors while reducing burdensome care with limited health benefits. This study examines whether the intervention, titled REASSURE, improves survivors' preparedness for survivorship. Up to 110 participants will be on study for up to 18 months.

Detailed Description: The investigators plan a single site prospective, randomized, trial that will compare the effect of REASSURE on survivor preparedness against usual care. Survivors will be identified from breast oncology clinics within UW Health. REASSURE is comprised of three components: 1) the REASSURE PRO assessment, which assesses survivors' symptoms and/or concerns, 2) a recommendation for or against a follow-up visit based on survivors reported symptoms /concerns using pre-established thresholds, and 3) REASSURE survivorship messaging. * Primary Objective * Compare survivors' preparedness for survivorship with REASSURE versus usual care. * Secondary Objectives * Determine the acceptability of REASSURE for survivors living in rural and non-rural areas. * Assess changes in survivor reported symptoms and number of follow-up visits with REASSURE versus usual care.